Lokon 50 Injection contains Nandrolone Decanoate 50 mg, an anabolic androgenic steroid used primarily for the treatment of anemia associated with chronic kidney failure, osteoporosis, and certain types of breast cancer. Nandrolone Decanoate promotes protein synthesis, increases nitrogen retention, and stimulates erythropoiesis, thereby enhancing muscle mass and strength. It is administered via intramuscular injection, allowing for a slow and sustained release of the active compound. Lokon 50 Injection is indicated in patients requiring anabolic support to improve physical condition and recovery, particularly in cases of catabolic states or muscle wasting disorders. Dosage and duration of treatment should be individualized based on the patient’s clinical response and underlying condition, with careful monitoring to minimize adverse effects. Common side effects may include fluid retention, hypertension, acne, and virilization symptoms, especially in female patients. Contraindications include hypersensitivity to nandrolone or any component of the formulation, prostate or breast carcinoma in males, and pregnancy or lactation in females. Caution is advised in patients with cardiovascular, hepatic, or renal impairment. Lokon 50 Injection should be used under strict medical supervision to ensure efficacy and safety.